Strides Arcolab has received US FDA approval for its oral dosage forms manufacturing site in Bangalore (KRS Gardens) for manufacturing oral products for the US markets. This facility manufactures oral dosage forms such as coated tablets, hard gelatine capsules, etc., The manufacturing plant supports important current and future submissions for the US market.

Venkat Iyer, CEO-India operations, said, " The continued US FDA approval of the facility is an important milestone for the company's US strategy and will support important product approvals and introductions."

Strides has a major presence in developed markets such as US, Canada and part of Europe and in developing countries such as Africa and Asia. It has a significant presence in the domestic market through Grandix. The company has manufacturing plants in Mexico, Italy, Poland, Singapore and India.